Study Uncovers Potential Gene Therapy for Late-Stage Parkinson’s Side-Effects

“Northwestern Medicine scientists have discovered that suppressing excitatory synaptic transmission in a small group of neurons in the brain may reverse levodopa-induced dyskinesia in patients with late-stage Parkinson’s disease without reducing the symptomatic benefits of levodopa treatment, according to a recent study published in Neuron. The post Study Uncovers Potential Gene Therapy for Late-Stage Parkinson’s Side-Effects appeared first on News Center .

Summary generated from the RSS feed of Northwestern Feinberg News. All article rights belong to the original publisher. Click through to read the full piece on news.feinberg.northwestern.edu.